Skip to content
10-Q

Quarterly Report

CANCER CAPITAL CORP.

0001554795-24-000126

← back to feed
Filed
May 9, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 6, 2024 6.15M sh
Operating Cash Flow Q1 2024 · Mar 31, 2024 −$3.5K
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$4.2K
Cash And Equivalents Q1 2024 · Mar 31, 2024 $12.66K
Cash And Equivalents Q1 2024 · Dec 31, 2023 $16.16K
Stockholders Equity Q1 2024 · Mar 31, 2024 −$465.33K
Stockholders Equity Q1 2024 · Dec 31, 2023 −$449.39K
Stockholders Equity Q1 2024 · Mar 31, 2023 −$423.01K
Stockholders Equity Q1 2024 · Dec 31, 2022 −$411.6K
Current Liabilities Q1 2024 · Mar 31, 2024 $447.99K
Current Liabilities Q1 2024 · Dec 31, 2023 $465.55K
Total Liabilities Q1 2024 · Mar 31, 2024 $447.99K
Total Liabilities Q1 2024 · Dec 31, 2023 $465.55K
Current Assets Q1 2024 · Mar 31, 2024 $12.66K
Current Assets Q1 2024 · Dec 31, 2023 $16.16K
Total Assets Q1 2024 · Mar 31, 2024 $12.66K
Total Assets Q1 2024 · Dec 31, 2023 $16.16K
Sga Expense Q1 2024 · Mar 31, 2024 $10.05K
Sga Expense Q1 2024 · Mar 31, 2023 $5.7K
Net Income Q1 2024 · Mar 31, 2024 −$15.94K
Net Income Q1 2024 · Mar 31, 2023 −$11.41K
Operating Income Q1 2024 · Mar 31, 2024 −$10.05K
Operating Income Q1 2024 · Mar 31, 2023 −$5.7K